PortfoliosLab logoPortfoliosLab logo
MMSI vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MMSI vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merit Medical Systems, Inc. (MMSI) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MMSI achieves a -21.49% return, which is significantly lower than LLY's 4.31% return. Over the past 10 years, MMSI has underperformed LLY with an annualized return of 13.96%, while LLY has yielded a comparatively higher 33.26% annualized return.


MMSI

1D
2.87%
1M
7.84%
YTD
-21.49%
6M
-20.81%
1Y
-25.80%
3Y*
-5.57%
5Y*
1.43%
10Y*
13.96%

LLY

1D
0.92%
1M
4.91%
YTD
4.31%
6M
4.09%
1Y
44.61%
3Y*
35.49%
5Y*
38.45%
10Y*
33.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MMSI vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MMSI
Merit Medical Systems, Inc.
-21.49%-8.87%27.33%7.56%13.35%12.23%77.80%-44.06%29.19%63.02%
LLY
Eli Lilly and Company
4.31%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Correlation

The correlation between MMSI and LLY is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Feb 26, 1992

0.18

Fundamentals

Market Cap

MMSI:

$4.15B

LLY:

$1.00T

EPS

MMSI:

$2.32

LLY:

$28.14

PE Ratio

MMSI:

29.87

LLY:

39.70

PEG Ratio

MMSI:

1.10

LLY:

0.80

PS Ratio

MMSI:

2.70

LLY:

13.89

PB Ratio

MMSI:

2.55

LLY:

32.08

Total Revenue (TTM)

MMSI:

$1.54B

LLY:

$72.25B

Gross Profit (TTM)

MMSI:

$751.05M

LLY:

$59.75B

EBITDA (TTM)

MMSI:

$299.40M

LLY:

$32.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MMSI vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MMSI
MMSI Risk / Return Rank: 1212
Overall Rank
MMSI Sharpe Ratio Rank: 99
Sharpe Ratio Rank
MMSI Sortino Ratio Rank: 1212
Sortino Ratio Rank
MMSI Omega Ratio Rank: 1212
Omega Ratio Rank
MMSI Calmar Ratio Rank: 1717
Calmar Ratio Rank
MMSI Martin Ratio Rank: 1212
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 7575
Overall Rank
LLY Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 7272
Sortino Ratio Rank
LLY Omega Ratio Rank: 7474
Omega Ratio Rank
LLY Calmar Ratio Rank: 7575
Calmar Ratio Rank
LLY Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MMSI vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Merit Medical Systems, Inc. (MMSI) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MMSILLYDifference
Sharpe ratioReturn per unit of total volatility

-2.01

Sortino ratioReturn per unit of downside risk

-2.78

Omega ratioGain probability vs. loss probability

0.87

1.24

-0.37

Calmar ratioReturn relative to maximum drawdown

-0.70

1.93

-2.63

Martin ratioReturn relative to average drawdown

-1.31

4.83

-6.14

MMSI vs. LLY - Sharpe Ratio Comparison

The current MMSI Sharpe Ratio is -0.83, which is lower than the LLY Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of MMSI and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MMSI vs. LLY - Drawdown Comparison

The maximum MMSI drawdown since its inception was -74.19%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for MMSI and LLY.


Loading charts...

Drawdown Indicators


MMSILLYDifference

Max Drawdown

Largest peak-to-trough decline

-74.19%

-68.24%

-5.95%

Max Drawdown (1Y)

Largest decline over 1 year

-37.18%

-23.18%

-14.00%

Max Drawdown (3Y)

Largest decline over 3 years

-45.32%

-34.48%

-10.84%

Max Drawdown (5Y)

Largest decline over 5 years

-45.32%

-34.48%

-10.84%

Max Drawdown (10Y)

Largest decline over 10 years

-68.67%

-34.48%

-34.19%

Current Drawdown

Current decline from peak

-37.26%

-3.76%

-33.50%

Average Drawdown

Average peak-to-trough decline

-33.09%

-19.20%

-13.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.74%

9.26%

+10.48%

Volatility

MMSI vs. LLY - Volatility Comparison

Merit Medical Systems, Inc. (MMSI) has a higher volatility of 9.44% compared to Eli Lilly and Company (LLY) at 8.33%. This indicates that MMSI's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MMSILLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.44%

8.33%

+1.11%

Volatility (6M)

Calculated over the trailing 6-month period

24.08%

26.83%

-2.75%

Volatility (1Y)

Calculated over the trailing 1-year period

31.22%

37.83%

-6.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.77%

32.29%

-2.52%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

36.30%

30.20%

+6.10%

Dividends

MMSI vs. LLY - Dividend Comparison

MMSI has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.58%.


PositionTTM20252024202320222021202020192018201720162015
LLY
Eli Lilly and Company
0.58%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
MMSI
Merit Medical Systems, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

MMSI vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Merit Medical Systems, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
381.88M
19.80B
(MMSI) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

MMSI vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Merit Medical Systems, Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
48.4%
79.0%
Portfolio components
MMSI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merit Medical Systems, Inc. reported a gross profit of 184.80M and revenue of 381.88M. Therefore, the gross margin over that period was 48.4%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

MMSI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merit Medical Systems, Inc. reported an operating income of 44.16M and revenue of 381.88M, resulting in an operating margin of 11.6%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

MMSI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merit Medical Systems, Inc. reported a net income of 41.00M and revenue of 381.88M, resulting in a net margin of 10.7%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.


Frequently Asked Questions


MMSI and LLY have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MMSI has higher volatility (9.44%) compared to LLY (8.33%). In terms of maximum drawdown, MMSI dropped -74.19% vs LLY's -68.24%.

LLY currently has the higher Sharpe Ratio (1.19 vs -0.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MMSI and LLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer